Iron Regulator Hepcidin Exhibits Antiviral Activity against Hepatitis C Virus

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Liu, Hongyan ^a   Trinh, Thu Le ^a   Dong, Huijia ^a   Keith, Robertson ^b   Nelson, David ^a   Liu, Chen ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPCIDIN; STAT3 PROTEIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA METHYLATION; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HISTONE ACETYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL; MALE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; VIRUS INHIBITION; VIRUS REPLICATION;

ACETYLATION; ANTIMICROBIAL CATIONIC PEPTIDES; BLOTTING, WESTERN; CELL LINE; CELLS, CULTURED; DNA METHYLATION; HEPACIVIRUS; HEPATITIS C; HISTONES; HUMANS; IRON; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; STAT3 TRANSCRIPTION FACTOR;

EID: 84867692347     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046631     Document Type: Article

References (49)

1. Lauer GM, Walker BD, (2001) Hepatitis C virus infection. N Engl J Med 345: 41-52.
2. Shepard CW, Finelli L, Alter MJ, (2005) Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5: 558-567.
3. Charlton M, (2001) Hepatitis C infection in liver transplantation. Am J Transplant 1: 197-203.
4. Krause A, Neitz S, Magert HJ, Schulz A, Forssmann WG, et al. (2000) LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 480: 147-150.
5. Park CH, Valore EV, Waring AJ, Ganz T, (2001) Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276: 7806-7810.
6. Lauth X, Babon JJ, Stannard JA, Singh S, Nizet V, et al. (2005) Bass hepcidin synthesis, solution structure, antimicrobial activities and synergism, and in vivo hepatic response to bacterial infections. J Biol Chem 280: 9272-9282.
7. Wallace DF, Jones MD, Pedersen P, Rivas L, Sly LI, et al. (2006) Purification and partial characterisation of recombinant human hepcidin. Biochimie 88: 31-37.
8. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, et al. (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306: 2090-2093.
9. She H, Xiong S, Lin M, Zandi E, Giulivi C, et al. (2002) Iron activates NF-kappaB in Kupffer cells. Am J Physiol Gastrointest Liver Physiol 283: G719-726.
10. Gardi C, Arezzini B, Fortino V, Comporti M, (2002) Effect of free iron on collagen synthesis, cell proliferation and MMP-2 expression in rat hepatic stellate cells. Biochem Pharmacol 64: 1139-1145.
11. Alla V, Bonkovsky HL, (2005) Iron in nonhemochromatotic liver disorders. Semin Liver Dis 25: 461-472.
12. Pietrangelo A, (2007) Iron chelation beyond transfusion iron overload. Am J Hematol 82: 1142-1146.
13. Fujita N, Sugimoto R, Takeo M, Urawa N, Mifuji R, et al. (2007) Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C. Mol Med 13: 97-104.
14. Harrison-Findik DD, Schafer D, Klein E, Timchenko NA, Kulaksiz H, et al. (2006) Alcohol metabolism-mediated oxidative stress down-regulates hepcidin transcription and leads to increased duodenal iron transporter expression. J Biol Chem 281: 22974-22982.
15. Choi SO, Cho YS, Kim HL, Park JW, (2007) ROS mediate the hypoxic repression of the hepcidin gene by inhibiting C/EBPalpha and STAT-3. Biochem Biophys Res Commun 356: 312-317.
16. Miura K, Taura K, Kodama Y, Schnabl B, Brenner DA, (2008) Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity. Hepatology 48: 1420-1429.
17. Babitt JL, Huang FW, Wrighting DM, Xia Y, Sidis Y, et al. (2006) Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet 38: 531-539.
18. Wrighting DM, Andrews NC, (2006) Interleukin-6 induces hepcidin expression through STAT3. Blood 108: 3204-3209.
19. Pietrangelo A, Dierssen U, Valli L, Garuti C, Rump A, et al. (2007) STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo. Gastroenterology 132: 294-300.
20. Zhu H, Shang X, Terada N, Liu C, (2004) STAT3 induces anti-hepatitis C viral activity in liver cells. Biochem Biophys Res Commun 324: 518-528.
21. Yang CH, Murti A, Pfeffer LM, (1998) STAT3 complements defects in an interferon-resistant cell line: evidence for an essential role for STAT3 in interferon signaling and biological activities. Proc Natl Acad Sci U S A 95: 5568-5572.
22. Guo JT, Bichko VV, Seeger C, (2001) Effect of alpha interferon on the hepatitis C virus replicon. J Virol 75: 8516-8523.
23. Blight KJ, McKeating JA, Rice CM, (2002) Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol 76: 13001-13014.
24. Tscherne DM, Evans MJ, von Hahn T, Jones CT, Stamataki Z, et al. (2007) Superinfection exclusion in cells infected with hepatitis C virus. J Virol 81: 3693-3703.
25. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, et al. (2005) Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11: 791-796.
26. Nishina S, Hino K, Korenaga M, Vecchi C, Pietrangelo A, et al. (2008) Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription. Gastroenterology 134: 226-238.
27. Sugimoto R, Fujita N, Tomosugi N, Hara N, Miyachi H, et al. (2009) Impaired regulation of serum hepcidin during phlebotomy in patients with chronic hepatitis C. Hepatol Res 39: 619-624.
28. Verga Falzacappa MV, Vujic Spasic M, Kessler R, Stolte J, Hentze MW, et al. (2007) STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood 109: 353-358.
29. Ganz T, (2003) Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 102: 783-788.
30. Pietrangelo A, Trautwein C, (2004) Mechanisms of disease: The role of hepcidin in iron homeostasis-implications for hemochromatosis and other disorders. Nat Clin Pract Gastroenterol Hepatol 1: 39-45.
31. Kijima H, Sawada T, Tomosugi N, Kubota K, (2008) Expression of hepcidin mRNA is uniformly suppressed in hepatocellular carcinoma. BMC Cancer 8: 167.
32. Okada S, (1996) Iron-induced tissue damage and cancer: the role of reactive oxygen species-free radicals. Pathol Int 46: 311-332.
33. Pietrangelo A, (2004) Hereditary hemochromatosis-a new look at an old disease. N Engl J Med 350: 2383-2397.
34. Le NT, Richardson DR, (2002) The role of iron in cell cycle progression and the proliferation of neoplastic cells. Biochim Biophys Acta 1603: 31-46.
35. Nairz M, Fritsche G, Brunner P, Talasz H, Hantke K, et al. (2008) Interferon-gamma limits the availability of iron for intramacrophage Salmonella typhimurium. Eur J Immunol 38: 1923-1936.
36. Sow FB, Florence WC, Satoskar AR, Schlesinger LS, Zwilling BS, et al. (2007) Expression and localization of hepcidin in macrophages: a role in host defense against tuberculosis. J Leukoc Biol 82: 934-945.
37. Abd Elmonem E, Tharwa el S, Farag MA, Fawzy A, El Shinnawy SF, et al. (2009) Hepcidin mRNA level as a parameter of disease progression in chronic hepatitis C and hepatocellular carcinoma. J Egypt Natl Canc Inst 21: 333-342.
38. Fujita N, Sugimoto R, Motonishi S, Tomosugi N, Tanaka H, et al. (2008) Patients with chronic hepatitis C achieving a sustained virological response to peginterferon and ribavirin therapy recover from impaired hepcidin secretion. J Hepatol 49: 702-710.
39. Schwarz P, Strnad P, von Figura G, Janetzko A, Krayenbuhl P, et al. A novel monoclonal antibody immunoassay for the detection of human serum hepcidin. J Gastroenterol.
40. Tai AW, Benita Y, Peng LF, Kim SS, Sakamoto N, et al. (2009) A functional genomic screen identifies cellular cofactors of hepatitis C virus replication. Cell Host Microbe 5: 298-307.
41. Bartolomei G, Cevik RE, Marcello A, (2011) Modulation of hepatitis C virus replication by iron and hepcidin in Huh7 hepatocytes. J Gen Virol 92: 2072-2081.
42. Sledz CA, Holko M, de Veer MJ, Silverman RH, Williams BR, (2003) Activation of the interferon system by short-interfering RNAs. Nat Cell Biol 5: 834-839.
43. Kariko K, Bhuyan P, Capodici J, Weissman D, (2004) Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through toll-like receptor 3. J Immunol 172: 6545-6549.
44. Kim DH, Longo M, Han Y, Lundberg P, Cantin E, et al. (2004) Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase. Nat Biotechnol 22: 321-325.
45. Hornung V, Guenthner-Biller M, Bourquin C, Ablasser A, Schlee M, et al. (2005) Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat Med 11: 263-270.
46. Judge AD, Sood V, Shaw JR, Fang D, McClintock K, et al. (2005) Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat Biotechnol 23: 457-462.
47. Zhu H, Liu C, (2003) Interleukin-1 inhibits hepatitis C virus subgenomic RNA replication by activation of extracellular regulated kinase pathway. J Virol 77: 5493-5498.
48. Lukavsky PJ, (2009) Structure and function of HCV IRES domains. Virus Res 139: 166-171.
49. Fensterl V, Sen GC The ISG56/IFIT1 gene family. J Interferon Cytokine Res 31: 71-78.